[HTML][HTML] Two decades of SPECT/CT–the coming of age of a technology: an updated review of literature evidence

O Israel, O Pellet, L Biassoni, D De Palma… - European journal of …, 2019 - Springer
Purpose Single-photon emission computed tomography (SPECT) combined with computed
tomography (CT) was introduced as a hybrid SPECT/CT imaging modality two decades ago …

Theranostic approaches in nuclear medicine: current status and future prospects

L Filippi, A Chiaravalloti, O Schillaci… - Expert review of …, 2020 - Taylor & Francis
Introduction: Theranostics is an emerging field in which diagnosis and specific targeted
therapy are combined to achieve a personalized treatment approach to the patient. In …

[HTML][HTML] Expanding theranostic radiopharmaceuticals for tumor diagnosis and therapy

C Barca, CM Griessinger, A Faust, D Depke, M Essler… - Pharmaceuticals, 2021 - mdpi.com
Radioligand theranostics (RT) in oncology use cancer-type specific biomarkers and
molecular imaging (MI), including positron emission tomography (PET), single-photon …

Differentiated thyroid cancer theranostics: radioiodine and beyond

PS Choudhury, M Gupta - The British journal of radiology, 2018 - academic.oup.com
The term theranostics is the combination of a diagnostic tool that helps to define the right
therapeutic tool for specific disease. It signifies the “we know which sites require treatment …

Surgical management of the recurrent laryngeal nerve in thyroidectomy: American Head and Neck Society Consensus Statement

CE Fundakowski, NW Hales, N Agrawal… - Head & …, 2018 - Wiley Online Library
Abstract “I have noticed in operations of this kind, which I have seen performed by others
upon the living, and in a number of excisions, which I have myself performed on the dead …

Possible delayed diagnosis and treatment of metastatic differentiated thyroid cancer by adopting the 2015 ATA guidelines

D Albano, F Bertagna, M Bonacina… - European Journal of …, 2018 - academic.oup.com
Abstract Objective According to the 2015 American Thyroid Association (ATA) guidelines,
thyroid ablation by iodine-131 (I-131) therapy is absolutely recommended only in patients …

[HTML][HTML] To give or not to give? A critical appraisal of a clinical trial on radioiodine treatment

M Tuncel, A Vrachimis, A Campenni… - European journal of …, 2022 - Springer
Recently, Leboulleux et al. published the results of the ESTIMABL 2 trial [1]. It is an open-
label, randomised, phase III trial using a noninferiority comparison design. In this study …

Prognosis of high-risk papillary thyroid cancer patients with pre-ablation stimulated Tg< 1 ng/mL

T Tian, Y Kou, R Huang, B Liu - Endocrine Practice, 2019 - Elsevier
Objective: The prevalence of undetectable pre-ablation stimulated thyroglobulin (s-Tg) and
its clinical implications in high-risk papillary thyroid cancer (PTC) patients remain poorly …

Efficacy of low radioiodine activity versus intermediate-high activity in the ablation of low-risk differentiated thyroid cancer

D Albano, M Bonacina, R Durmo, F Bertagna… - Endocrine, 2020 - Springer
Purpose The aim of our study was to compare the efficacy of thyroid remnant ablation using
low (1.1 GBq) and intermediate-high radioiodine (RAI) activity (1.85–3.7 GBq) in low-risk …

Clinical applications of single-photon emission computed tomography/computed tomography in post-ablation 131iodine scintigraphy in children and young adults …

L Jiang, Y Xiang, R Huang, R Tian, B Liu - Pediatric Radiology, 2021 - Springer
Background The utility of integrated single-photon emission computed
tomography/computed tomography (SPECT/CT) in children and young adults with …